PMC:7597510 / 1177-1407 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":84,"end":95},"obj":"Body_part"},{"id":"T5","span":{"begin":104,"end":115},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma82780"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma82816"}],"text":"mately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases. The cause is generally accepted to be an abnormality in the immune "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T22","span":{"begin":18,"end":21},"obj":"Disease"},{"id":"T23","span":{"begin":46,"end":55},"obj":"Disease"}],"attributes":[{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"mately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases. The cause is generally accepted to be an abnormality in the immune "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":84,"end":95},"obj":"Chemical"},{"id":"T2","span":{"begin":104,"end":115},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_33563"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"}],"text":"mately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases. The cause is generally accepted to be an abnormality in the immune "}

{"project":"LitCovid-PubTator","denotations":[{"id":"47","span":{"begin":104,"end":115},"obj":"Chemical"},{"id":"51","span":{"begin":46,"end":55},"obj":"Disease"}],"attributes":[{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"MESH:D005732"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"mately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases. The cause is generally accepted to be an abnormality in the immune "}